-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cancer patients are at increased risk of acute ischemic stroke (AIS) , especially in the first month after diagnosis
.
Stroke risk varies by cancer type, but is generally higher in patients with advanced disease and adenocarcinoma
.
Cancer patients are at increased risk of acute ischemic stroke (AIS) , especially in the first month after diagnosis
Previous studies have found that comorbid cancers are associated with increased stroke severity, stroke progression, and poor functional outcomes
To investigate the clinical, radiographic, and safety prognostic differences between patients with AIS and those with active cancer treated with EVT
Using data from the MR CLEAN Registry, patients with active cancer (defined as cancer diagnosed within 12 months prior to stroke, metastatic disease, or current treatment for cancer) were compared with patients without cancer
.
Using data from the MR CLEAN Registry, patients with active cancer (defined as cancer diagnosed within 12 months prior to stroke, metastatic disease, or current treatment for cancer) were compared with patients without cancer
- Of the 2583 patients treated with EVT, 124 (4.
8%) had active cancer
Despite similar technical success, patients with active cancer have a significantly poorer prognosis following EVT
This study provides class I evidence that patients with active cancer with AIS treated with EVT have worse functional outcomes at 90 days than those without active cancer
Verschoof MA, Groot AE, de Bruijn SFTM, et al.
Clinical Outcome After Endovascular Treatment in Patients With Active Cancer and Ischemic Stroke: A MR CLEAN Registry Substudy [published online ahead of print, 2022 Jan 11].
Neurology.
2022;10.
1212/ WNL.
0000000000013316.
doi:10.
1212/WNL.
0000000000013316Leave a message here
